Therapeutic Developability Analysis

Antibody drug candidates with promising biochemical and biophysical properties can be selected at early stage of drug development. At LakePharma, a series of fast and small-scale tests, as well as in silico predictive tools are employed to serve as an additional selection criteria for better and safer therapeutic leads. 

     - CE-SDS (reducing and non-reducing), SE-HPLC, cIEF

     - DSF/DLS, PTM analysis

     - Octet (FcRn and Fc-gamma R binding profile)

     - Sequence liability analysis

     - Poly-specificity analysis

     - Hydrophobicity assessment, forced degradation study

View LakePharma PDF file on Antibody Developability Analysis.

Please contact LakePharma at inquiries@lakepharma.com for custom quotes and details.

Cat.# Service Name Timeline Size Price Quantity Request